Annual FCF
-$39.70 M
-$43.16 M-1248.78%
December 31, 2023
Summary
- As of March 10, 2025, LVTX annual free cash flow is -$39.70 million, with the most recent change of -$43.16 million (-1248.78%) on December 31, 2023.
- During the last 3 years, LVTX annual FCF has fallen by -$29.89 million (-304.75%).
- LVTX annual FCF is now -1248.78% below its all-time high of $3.46 million, reached on December 31, 2022.
Performance
LVTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$8.65 M
-$269.00 K-3.21%
September 30, 2024
Summary
- As of March 10, 2025, LVTX quarterly free cash flow is -$8.65 million, with the most recent change of -$269.00 thousand (-3.21%) on September 30, 2024.
- Over the past year, LVTX quarterly FCF has stayed the same.
- LVTX quarterly FCF is now -124.40% below its all-time high of $35.47 million, reached on December 31, 2022.
Performance
LVTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$28.63 M
-$1.54 M-5.69%
September 30, 2024
Summary
- As of March 10, 2025, LVTX TTM free cash flow is -$28.63 million, with the most recent change of -$1.54 million (-5.69%) on September 30, 2024.
- Over the past year, LVTX TTM FCF has stayed the same.
- LVTX TTM FCF is now -559.28% below its all-time high of $6.23 million, reached on September 30, 2023.
Performance
LVTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
LVTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1248.8% | 0.0% | 0.0% |
| 3 y3 years | -304.8% | 0.0% | 0.0% |
| 5 y5 years | -323.4% | 0.0% | 0.0% |
LVTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1248.8% | at low | -124.4% | +39.6% | -559.3% | +27.9% |
| 5 y | 5-year | -1248.8% | at low | -124.4% | +39.6% | -559.3% | +27.9% |
| alltime | all time | -1248.8% | at low | -124.4% | +39.6% | -559.3% | +27.9% |
LAVA Therapeutics NV Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.65 M(+3.2%) | -$28.63 M(+5.7%) |
| Jun 2024 | - | -$8.38 M(+645.2%) | -$27.09 M(-15.3%) |
| Mar 2024 | - | -$1.13 M(-89.2%) | -$31.99 M(-19.4%) |
| Dec 2023 | -$39.70 M(-1248.8%) | -$10.46 M(+47.1%) | -$39.70 M(-737.0%) |
| Sep 2023 | - | -$7.11 M(-46.5%) | $6.23 M(-740.6%) |
| Jun 2023 | - | -$13.29 M(+50.4%) | -$973.00 K(-137.8%) |
| Mar 2023 | - | -$8.84 M(-124.9%) | $2.57 M(-25.6%) |
| Dec 2022 | $3.46 M | $35.47 M(-347.7%) | $3.46 M(-108.7%) |
| Sep 2022 | - | -$14.32 M(+47.0%) | -$39.62 M(+16.9%) |
| Jun 2022 | - | -$9.74 M(+22.6%) | -$33.90 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.95 M(+4.6%) | -$32.70 M(+11.2%) |
| Dec 2021 | -$29.41 M(+199.8%) | -$7.60 M(-11.6%) | -$29.41 M(+1.7%) |
| Sep 2021 | - | -$8.60 M(+0.7%) | -$28.93 M(+18.2%) |
| Jun 2021 | - | -$8.54 M(+83.1%) | -$24.48 M(+106.0%) |
| Mar 2021 | - | -$4.67 M(-34.5%) | -$11.88 M(+21.1%) |
| Dec 2020 | -$9.81 M(+4.6%) | -$7.12 M(+71.5%) | -$9.81 M(+264.5%) |
| Sep 2020 | - | -$4.15 M(-202.4%) | -$2.69 M(-284.5%) |
| Jun 2020 | - | $4.05 M(-256.3%) | $1.46 M(-156.3%) |
| Mar 2020 | - | -$2.59 M | -$2.59 M |
| Dec 2019 | -$9.38 M | - | - |
FAQ
- What is LAVA Therapeutics NV annual free cash flow?
- What is the all time high annual FCF for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual FCF year-on-year change?
- What is LAVA Therapeutics NV quarterly free cash flow?
- What is the all time high quarterly FCF for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly FCF year-on-year change?
- What is LAVA Therapeutics NV TTM free cash flow?
- What is the all time high TTM FCF for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV TTM FCF year-on-year change?
What is LAVA Therapeutics NV annual free cash flow?
The current annual FCF of LVTX is -$39.70 M
What is the all time high annual FCF for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual free cash flow is $3.46 M
What is LAVA Therapeutics NV annual FCF year-on-year change?
Over the past year, LVTX annual free cash flow has changed by -$43.16 M (-1248.78%)
What is LAVA Therapeutics NV quarterly free cash flow?
The current quarterly FCF of LVTX is -$8.65 M
What is the all time high quarterly FCF for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly free cash flow is $35.47 M
What is LAVA Therapeutics NV quarterly FCF year-on-year change?
Over the past year, LVTX quarterly free cash flow has changed by $0.00 (0.00%)
What is LAVA Therapeutics NV TTM free cash flow?
The current TTM FCF of LVTX is -$28.63 M
What is the all time high TTM FCF for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM free cash flow is $6.23 M
What is LAVA Therapeutics NV TTM FCF year-on-year change?
Over the past year, LVTX TTM free cash flow has changed by $0.00 (0.00%)